HYSTER-YALE, INC.

HY

CIK 0001173514 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$923M
↓-13.5% -$144Mvs FY2024 (Q4)
Gross Profit
$131M
↓-36.9% -$77Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
32/100
  • Profitability
    0ROIC -1.9% (10% = solid, 20%+ = moat)
  • Liquidity
    42Current Ratio 1.34 (above 1.5 = solid)
  • Leverage
    50D/E 1.00 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 1.86x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -13.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 0.2% · trend -5.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project HY's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 26.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$44.55
Total enterprise IV
$787M
Diluted shares
0.02B
Terminal PV
$611M (78% of total)
Year-5 FCF
$72M
YearProjected FCFDiscounted PV
+1$30M$27M
+2$37M$30M
+3$46M$35M
+4$58M$39M
+5$72M$45M
Terminal$984M$611M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$63M
investment in PP&E
Dividends paid (TTM)
$25M
cash returned to holders
Stock buybacks (TTM)
$5M
share count reduction
Stock-based comp (TTM)
$8M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2.02B
everything owned
Total liabilities
$1.53B
everything owed
Stockholders' equity
$472M
shareholder claim
Net debt
$408M
LT debt minus cash

Recent performance · 61 quarters

Revenue↓-13.5% -$144M
$923M
Net Income↓-113.4% -$20M
$-2M
Free Cash Flow↓-47.6% -$30M
$33M
Operating Margin↓-3.0pts
0.2%

Drill down